Skip to content

Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry.

Aug 2026 · European Heart Journal · 0 citations
Medicine

TL;DR

In patients with suspected ischaemic heart disease undergoing invasive coronary angiography, coronary microvascular dysfunction defined by MRR ≤2.5 was observed among one-third of patients, and was associated with an increased risk of a composite of all-cause death, myocardial infarction, clinically-driven repeat revascularisation, or hospitalisation for heart failure.

View source

Similar papers

Open access Sep 2026

Angiography-derived index of microcirculatory resistance in older patients with acute coronary syndrome undergoing percutaneous coronary intervention.

BACKGROUND Coronary microvascular dysfunction (CMD) plays a significant role in the prognosis of patients with ischaemic heart disease. AIMS In this analysis of the study to Improve Clinical Outcomes in high-risk patieNts with acute coronary syndrome (ICON1), we investigated the association between CMD and long-term...

M. Magistri, C. Collet, F. Ribichini et al. · 0 citations
Sep 2026

Prognostic value of D-SPECT-derived myocardial flow reserve in detecting coronary microvascular disease and predicting outcomes after complete revascularization: a two-center pilot study.

In this two-center cohort of patients with complete revascularization after PCI, D-SPECT-derived CMD is associated with a 2-fold increased risk of future MACE, independent of traditional risk factors and perfusion abnormalities.

Rong Wang, Jing Bai, Ping Xie et al. · 0 citations
Meta-analysis Open access Oct 2026

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis

Background Coronary microvascular dysfunction (CMD) is a complication of severe aortic stenosis. Its prevalence after transcatheter aortic valve implantation (TAVI) and prognostic significance are understudied, as are the post-TAVI trajectories of microvascular indices. Aims The aims of this study were to determine the...

Maethas Panyawongkhanti, Peerawat Chintrakulchai, C. Tanking et al. · 0 citations
Oct 2026

Classification and Outcomes of Coronary Microvascular Disease in Myocardial Infarction and Angina With Nonobstructive Coronary Arteries.

BACKGROUND Myocardial infarction with nonobstructive coronary arteries (MINOCAs) and angina with nonobstructive coronary arteries (ANOCAs) present diagnostic and therapeutic challenges. We assessed the frequency of coronary microvascular disease (CMD) and its subtypes in MINOCA compared with ANOCA and evaluated long-te...

Justin G. Carrington, K. Nogami, Y. Kanaji et al. · 0 citations
Open access Oct 2026

THE STUDY OF INVASIVE CORONARY ANGIOGRAPHIC PROFILE IN PATIENTS WITH ANGINA AND MYOCARDIAL BRIDGING

Background: Myocardial bridging (MB) is a congenital coronary artery anomaly in which a segment of an epicardial coronary artery follows an intramyocardial course, resulting in dynamic systolic compression of the tunneled vessel. Although traditionally considered a benign anatomical variant, increasing evidence suggest...

Shruti Madhukar Koli, S. Ambar, S. Patted et al. · 0 citations
Open access Aug 2026

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

BACKGROUND AND AIMS Comprehensive evaluation by invasive coronary function test (CFT) of patients with angina and non-obstructive coronary artery disease is recommended in current guidelines. The prognosis of patients with CFT-proven coronary vasomotor dysfunction (CVDys) is less well-known. METHODS Patients that pro...

C. Crooijmans, F. Adriaansen, J. Meeder et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.